Back to search

Article

A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic Control

2023-11-07

Abstract excerpt

<title>Abstract</title> <p>Accumulating data from several large, placebo-controlled studies suggests that sodium-glucose transporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor (GLP-1) receptor agonists offer therapeutic benefits in the management of cardiovascular diseases, regardless of the patient's diabetic status. In addition to their effects on glucose excretion, SGLT2-inhibitors have a posit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc3ce726-1526-5404-b52b-e9f9f2356f21
DOI
10.21203/rs.3.rs-3569600/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic ControlDOI 10.21203/rs.3.rs-3569600/v1
A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic ControlSemantic proximity
Preclinical Modeling of Metabolic Syndrome to Study the Pleiotropic Effects of Novel Antidiabetic Therapy Independent of ObesitySemantic proximity
SGLT2 Inhibitors and Potential Applications in Treating Metabolic SyndromeSemantic proximity
Mechanisms and Outcomes of Metabolic Surgery in Type 2 DiabetesSemantic proximity
Obesity and sarcopenia affect the metabolite profiles of pet dogsSemantic proximity
Integrated Ultrasound Characterization of the Diet-Induced Obesity (Dio) Model in Young Adult C57bl/6j Mice: Assessment of Cardiovascular, Renal and Hepatic ChangesSemantic proximity
Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintySemantic proximity
Canine Obesity: Contributing Factors and Body Condition EvaluationSemantic proximity
Obesity and sarcopenia affect the metabolite profiles of pet dogsSemantic proximity
A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulationSemantic proximity
High Fat Rodent Models of Type 2 Diabetes: From Rodent to HumanSemantic proximity
Approach to assessing determinants of glucose homeostasis in the conscious mouse.Semantic proximity
Select a neighboring publication to make it the new centre.